Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly ...
Santé log

Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...
Science News

How these strange cells may explain the origin of complex life

The tiny pantheon known as the Asgard archaea bear traits that hint at how plants, animals and fungi emerged on Earth.
Le Lézard

ALLEGRIA THERAPEUTICS SECURES USD 5.1 MILLION SEED EXTENSION FINANCING

Allegria Therapeutics (ALLEGRIA), a Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases, announced today the successful completion of a USD 5.1 ...
The Manila Times

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growth ex vivo ...

How India is uniquely positioned to champion Global South interests in modernising BWC

India’s membership in the Australia Group since 2018 and consistent diplomatic support for the Biological Weapons Convention ...